Thus, glycolysis/OXPHOS inhibition by DDM and FDR treatment may induce cancer metabolic reprogramming via a novel PI3K/AKT/mTOR/P53NF-κB/VEGF pathway in BC cells. The gene discussed is MTOR; the disease is cancer.